|
CSGALNACT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.45469999946313E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.77750000460864E-08 |
| Normal-vs-Stage2 |
9.601000E-01 |
| Normal-vs-Stage3 |
1.833390E-04 |
| Normal-vs-Stage4 |
1.977290E-03 |
| Stage1-vs-Stage2 |
6.603400E-04 |
| Stage1-vs-Stage3 |
4.975800E-01 |
| Stage1-vs-Stage4 |
5.990000E-01 |
| Stage2-vs-Stage3 |
5.704800E-03 |
| Stage2-vs-Stage4 |
1.309600E-02 |
| Stage3-vs-Stage4 |
9.920800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.03010000108395E-08 |
| Normal-vs-AfricanAmerican |
1.331700E-02 |
| Normal-vs-Asian |
9.52520000000456E-05 |
| Caucasian-vs-AfricanAmerican |
9.282200E-01 |
| Caucasian-vs-Asian |
2.704600E-01 |
| AfricanAmerican-vs-Asian |
5.358200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.637100E-04 |
| Normal-vs-Female |
7.07610000039161E-07 |
| Male-vs-Female |
6.442600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.47279999096872E-09 |
| Normal-vs-Age(41-60Yrs) |
2.607600E-04 |
| Normal-vs-Age(61-80Yrs) |
9.811700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.376650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.575300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.045400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.749400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.427020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.709000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.287400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.981000E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
2.461800E-01 |
| Classical-VS-Normal |
1.2544965066752E-11 |
| Tall-VS-Follicular |
1.51610002330216E-09 |
| Tall-VS-Other |
2.930600E-01 |
| Tall-VS-Normal |
1.425910E-04 |
| Follicular-VS-Other |
2.793800E-02 |
| Follicular-VS-Normal |
3.944300E-03 |
| Other-VS-Normal |
4.408600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.662200E-02 |
| Normal-vs-N1 |
1.65008999999383E-05 |
| N0-vs-N1 |
1.375170E-03 |
|
|
